Doxycycline Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition
Doxycycline Hydrochloride Price Trend, Index and Forecast
Track the latest insights on doxycycline hydrochloride price trend and forecast with detailed analysis of regional fluctuations and market dynamics across North America, Latin America, Central Europe, Western Europe, Eastern Europe, Middle East, North Africa, West Africa, Central and Southern Africa, Central Asia, Southeast Asia, South Asia, East Asia, and Oceania.
Doxycycline Hydrochloride Prices Outlook Q3 2025
- USA: USD 49090/MT
- China: USD 43977/MT
- Germany: USD 49693/MT
- India: USD 48225/MT
- Brazil: USD 49135/MT
Doxycycline Hydrochloride Price Chart
Get real-time access to monthly/quarterly/yearly prices Request Sample
During the third quarter of 2025, the doxycycline hydrochloride prices in the USA reached 49090 USD/MT in September. Prices moved upward as demand from pharmaceutical formulation units and hospital supply channels increased. Higher procurement for antibiotic formulations and regulated healthcare markets supported buying activity. Buyers aligned sourcing with production schedules and regulatory documentation requirements, while steady API availability influenced purchasing strategies.
During the third quarter of 2025, the doxycycline hydrochloride prices in China reached 43977 USD/MT in September. Prices increased due to steady export demand and sustained domestic consumption from API manufacturers. Improved order visibility from overseas buyers supported procurement activity. Buyers coordinated sourcing with manufacturing schedules, supported by sufficient domestic production capacity.
During the third quarter of 2025, the doxycycline hydrochloride prices in Germany reached 49693 USD/MT in September. Prices declined as demand from pharmaceutical distributors and formulation units softened. Inventory drawdowns and cautious procurement behavior influenced sourcing decisions. Buyers focused on meeting immediate formulation needs while managing compliance and batch documentation requirements.
During the third quarter of 2025, the doxycycline hydrochloride prices in India reached 48225 USD/MT in September. Prices moved upward due to strong demand from export-oriented pharmaceutical manufacturers and domestic formulation units. Increased supplies to regulated and semi-regulated markets supported consumption. Buyers aligned procurement with production planning and regulatory timelines.
During the third quarter of 2025, the doxycycline hydrochloride prices in Brazil reached 49135 USD/MT in September. Prices declined amid reduced public healthcare procurement and cautious distributor purchasing. Adequate import availability influenced sourcing behavior. Buyers limited purchases to near-term operational requirements and tender-based demand.
Doxycycline Hydrochloride Prices Outlook Q2 2025
- USA: USD 48270/MT
- China: USD 43370/MT
- Germany: USD 50348/MT
- India: USD 47140/MT
- Brazil: USD 51023/MT
During the second quarter of 2025, the doxycycline hydrochloride prices in the USA reached 48270 USD/MT in June. Demand from pharmaceutical formulation units and healthcare supply chains influenced procurement activity. Buyers aligned sourcing with production schedules and inventory planning.
During the second quarter of 2025, the doxycycline hydrochloride prices in China reached 43370 USD/MT in June. Consumption from export-oriented API manufacturing shaped procurement patterns. Domestic production capacity and inventory availability supported material access.
During the second quarter of 2025, the doxycycline hydrochloride prices in Germany reached 50348 USD/MT in June. Demand from pharmaceutical distributors and formulation units guided sourcing decisions. Buyers coordinated procurement with regulatory compliance and batch documentation requirements.
During the second quarter of 2025, the doxycycline hydrochloride prices in India reached 47140 USD/MT in June. Procurement was influenced by export demand and domestic formulation requirements. Buyers structured sourcing around confirmed manufacturing schedules.
During the second quarter of 2025, the doxycycline hydrochloride prices in Brazil reached 51023 USD/MT in June. Demand from public healthcare tenders and pharmaceutical distributors shaped procurement volumes. Import availability and logistics considerations influenced sourcing timelines.
Regional Coverage
The report provides a detailed analysis of the market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of FOB and CIF prices, as well as the key factors influencing the doxycycline hydrochloride prices.
Europe Doxycycline Hydrochloride Price Trend
Q3 2025:
As per the doxycycline hydrochloride price index, Europe experienced downward price movement, led by declining prices in Germany. Softer demand from pharmaceutical distributors and formulation units influenced regional procurement behavior. Buyers relied on existing inventories and long-term supply contracts, reducing spot market activity. Regulatory compliance requirements, batch certification, and documentation timelines continued to shape sourcing decisions. Import availability supported supply continuity, with procurement volumes aligned closely to confirmed formulation schedules rather than forward inventory accumulation.
Q2 2025:
In Europe, doxycycline hydrochloride demand was shaped by routine pharmaceutical formulation activity and distributor-led sourcing across regulated healthcare markets. Buyers coordinated procurement with production planning, quality assurance protocols, and regulatory documentation requirements. Import availability and established logistics networks supported material access. Purchasing strategies emphasized specification compliance, traceability, and uninterrupted supply for hospital and retail pharmaceutical channels.
This analysis can be extended to include detailed doxycycline hydrochloride price information for a comprehensive list of countries.
| Region | Countries Covered |
|---|---|
| Europe | Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Doxycycline Hydrochloride Price Trend
Q3 2025:
As per the doxycycline hydrochloride price index, North America experienced upward price movement, driven by increases in the USA. Improved demand from hospital procurement programs and pharmaceutical formulation units supported consumption. Buyers advanced sourcing to meet prescription demand and inventory requirements. Domestic distribution networks and import availability supported supply continuity, while procurement decisions remained aligned with confirmed healthcare demand rather than speculative stocking.
Q2 2025:
In North America, doxycycline hydrochloride demand reflected procurement aligned with pharmaceutical formulation schedules and hospital supply planning. Buyers coordinated sourcing with inventory management, regulatory compliance, and batch release timelines. Import flows and established supplier relationships supported material availability, while procurement strategies focused on maintaining continuity for regulated manufacturing and healthcare distribution.
Specific doxycycline hydrochloride historical data within the United States and Canada can also be provided.
| Region | Countries Covered |
|---|---|
| North America | United States and Canada |
Middle East and Africa Doxycycline Hydrochloride Price Trend
Q3 2025:
As per doxycycline hydrochloride price chart, the prices in the Middle East and Africa fluctuated due to a complex interplay of factors, primarily driven by supply chain disruptions, seasonal demand shifts, and geopolitical influences.
Q2 2025:
The report explores the doxycycline hydrochloride pricing trends and doxycycline hydrochloride price chart in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on doxycycline hydrochloride prices for countries can also be provided.
| Region | Countries Covered |
|---|---|
| Middle East & Africa | Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Doxycycline Hydrochloride Price Trend
Q3 2025:
As per the doxycycline hydrochloride price index, Asia Pacific experienced upward price movement, supported by increases in China and India. Strong demand from export-oriented pharmaceutical manufacturers and domestic formulation units drove regional consumption. Buyers adjusted sourcing strategies based on export order visibility and regulatory destination requirements. Domestic production capacity and regional trade flows supported material availability across key manufacturing hubs.
Q2 2025:
In Asia Pacific, doxycycline hydrochloride demand was shaped by pharmaceutical formulation activity across China and India. Buyers coordinated procurement with production planning, export order schedules, and compliance documentation requirements. Domestic supply availability and regional trade supported continuity, while procurement strategies emphasized operational alignment and batch traceability.
This doxycycline hydrochloride price analysis can be expanded to include a comprehensive list of countries within the region.
| Region | Countries Covered |
|---|---|
| Asia Pacific | China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Doxycycline Hydrochloride Price Trend
Q3 2025:
As per the doxycycline hydrochloride price index, Latin America experienced downward price movement, led by declining prices in Brazil. Reduced public healthcare procurement and cautious distributor purchasing softened regional consumption. Buyers limited sourcing volumes amid inventory optimization efforts. Import availability supported supply, allowing procurement to remain closely aligned with confirmed formulation and tender-based requirements.
Q2 2025:
In Latin America, doxycycline hydrochloride procurement reflected demand from pharmaceutical distributors and formulation units supplying public and private healthcare channels. Buyers scheduled sourcing based on confirmed supply commitments and tender cycles. Import flows and logistics coordination supported material availability, while procurement strategies focused on ensuring continuity of supply.
This comprehensive review can be extended to include specific countries within the region.
| Region | Countries Covered |
|---|---|
| Latin America | Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Doxycycline Hydrochloride Pricing Report, Market Analysis, and News
IMARC's latest publication, “Doxycycline Hydrochloride Prices, Trend, Chart, Demand, Market Analysis, News, Historical and Forecast Data Report 2025 Edition,” presents a detailed examination of the doxycycline hydrochloride market, providing insights into both global and regional trends that are shaping prices. This report delves into the spot price of doxycycline hydrochloride at major ports and analyzes the composition of prices, including FOB and CIF terms. It also presents detailed doxycycline hydrochloride prices trend analysis by region, covering North America, Europe, Asia Pacific, Latin America, and Middle East and Africa. The factors affecting doxycycline hydrochloride pricing, such as the dynamics of supply and demand, geopolitical influences, and sector-specific developments, are thoroughly explored. This comprehensive report helps stakeholders stay informed with the latest market news, regulatory updates, and technological progress, facilitating informed strategic decision-making and forecasting.
Doxycycline Hydrochloride Industry Analysis
The global doxycycline hydrochloride industry size reached 89.6 Thousand Tons in 2025. By 2034, IMARC Group expects the market to reach 131.2 Thousand Tons, at a projected CAGR of 4.33% during 2026-2034. Market growth is driven by sustained demand for broad-spectrum antibiotics, rising incidence of bacterial infections, expanding generic pharmaceutical manufacturing, and continued reliance on doxycycline hydrochloride across regulated human and veterinary healthcare markets worldwide.
Latest News and Developments:
- June 2025: Alembic Pharmaceuticals Limited announced that it received final approval from the United States Food and Drug Administration (US FDA) for its Doxorubicin Hydrochloride Liposome Injection in strengths of 20 mg/10 mL and 50 mg/25 mL. The product is indicated for the treatment of ovarian cancer, AIDS-related Kaposi’s sarcoma, and multiple myeloma, and is manufactured at the company’s oncology formulation facility in India.
- June 2025: A study by scientists published on BioRxiv investigated doxycycline hydrochloride release from a collagen hydrogel containing entrapped γ-cyclodextrin oligomers to improve controlled drug delivery. The research found that incorporating these cyclodextrin oligomers enhanced the amount of doxycycline hydrochloride that could be released by approximately 220% and slowed its release rate significantly compared to conventional formulations.
Product Description
Doxycycline hydrochloride is an antibiotic medication that belongs to the tetracycline class. It helps the immune system to fight off several infections. It is available in different forms like tablets, capsules, and oral suspensions. It has a longer half-life compared to some other antibiotics, allowing for less frequent dosing and improved patient adherence to the treatment regimen. It is accessible in brand-name and generic forms, which makes it approachable for patients in need of antibiotic therapy.
Furthermore, it is prescribed to treat multiple bacterial infections, such as respiratory tract, urinary tract, skin and eye infections, and sexually transmitted diseases (STDs). It is also utilized for the treatment of moderate to severe acne vulgaris due to its anti-inflammatory properties and ability to reduce the presence of acne-causing bacteria on the skin. Besides this, it is used as a prophylactic medication to prevent malaria in individuals traveling to areas where malaria is prevalent.
Report Coverage
| Key Attributes | Details |
|---|---|
| Product Name | Doxycycline Hydrochloride |
| Report Features | Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Doxycycline Hydrochloride Price Analysis, and Segment-Wise Assessment. |
| Currency/Units | US$ (Data can also be provided in local currency) or Metric Tons |
| Region/Countries Covered | The current coverage includes analysis at the global and regional levels only. Based on your requirements, we can also customize the report and provide specific information for the following countries: Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand* Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece* North America: United States and Canada Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru* Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco* *The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
| Information Covered for Key Suppliers |
|
| Customization Scope | The report can be customized as per the requirements of the customer |
| Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
Plan B: Quarterly Updates - Annual Subscription
Plan C: Biannually Updates - Annual Subscription
|
| Post-Sale Analyst Support | 360-degree analyst support after report delivery |
| Delivery Format | PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of doxycycline hydrochloride pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting doxycycline hydrochloride price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The doxycycline hydrochloride price charts ensure our clients remain at the forefront of the industry.
Need more help?
- Speak to our experienced analysts for insights on the current market scenarios.
- Include additional segments and countries to customize the report as per your requirement.
- Gain an unparalleled competitive advantage in your domain by understanding how to utilize the report and positively impacting your operations and revenue.
- For further assistance, please connect with our analysts.
Request Customization
Inquire Before Buying
Speak to an Analyst
Request Brochure
Benefits of Customization
- Personalize this research
- Triangulate with your data
- Get data as per your format and definition
- Gain a deeper dive into a specific application, geography, customer, or competitor
- Any level of personalization
Get in Touch With Us
UNITED STATES
Phone: +1-201-971-6302
INDIA
Phone: +91-120-433-0800
UNITED KINGDOM
Phone: +44-753-714-6104
Email: sales@imarcgroup.com
Client Testimonials
.webp)
.webp){kind=logo}
Why Choose Us
IMARC offers trustworthy, data-centric insights into commodity pricing and evolving market trends, enabling businesses to make well-informed decisions in areas such as procurement, strategic planning, and investments. With in-depth knowledge spanning more than 1000 commodities and a vast global presence in over 150 countries, we provide tailored, actionable intelligence designed to meet the specific needs of diverse industries and markets.
1000
+Commodities
150
+Countries Covered
3000
+Clients
20
+Industry
Robust Methodologies & Extensive Resources
IMARC delivers precise commodity pricing insights using proven methodologies and a wealth of data to support strategic decision-making.
Subscription-Based Databases
Our extensive databases provide detailed commodity pricing, import-export trade statistics, and shipment-level tracking for comprehensive market analysis.
Primary Research-Driven Insights
Through direct supplier surveys and expert interviews, we gather real-time market data to enhance pricing accuracy and trend forecasting.
Extensive Secondary Research
We analyze industry reports, trade publications, and market studies to offer tailored intelligence and actionable commodity market insights.
Trusted by 3000+ industry leaders worldwide to drive data-backed decisions. From global manufacturers to government agencies, our clients rely on us for accurate pricing, deep market intelligence, and forward-looking insights.